dotmedicalblog.wordpress.com
FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs
Typically used in Type 2 Diabetes they decrease glucose absorption and increase urinary glucose excretion. FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs.